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Background: Aging involves multiple biologically complex processes characterized by a decline in cellular homeostasis
over time leading to a loss and impairment of physiological integrity and function. Specific cellular hallmarks of aging
include abnormal gene expression patterns, shortened telomeres and associated biological dysfunction. Like all organs,
the lung demonstrates both physiological and structural changes with age that result in a progressive decrease in lung
function in healthy individuals. Cigarette smoking accelerates lung function decline over time, suggesting smoking
accelerates aging of the lung. Based on this data, we hypothesized that cigarette smoking accelerates the aging of the
small airway epithelium, the cells that take the initial brunt of inhaled toxins from the cigarette smoke and one of the
primary sites of pathology associated with cigarette smoking.
Methods: Using the sensitive molecular parameters of aging-related gene expression and telomere length, the aging
process of the small airway epithelium was assessed in age matched healthy nonsmokers and healthy smokers with no
physical manifestation of lung disease or abnormalities in lung function.
Results: Analysis of a 73 gene aging signature demonstrated that smoking significantly dysregulates 18 aging-related
genes in the small airway epithelium. In an independent cohort of male subjects, smoking significantly reduced telomere
length in the small airway epithelium of smokers by 14% compared to nonsmokers.
Conclusion: These data provide biologic evidence that smoking accelerates aging of the small airway epithelium.
Keywords: Aging, Small airway epithelium, Telomere, SmokingIntroduction
Aging is a complex natural process that affects all living
organisms, and can be broadly defined as a progressive
decline in homeostasis of biological processes that leads
to a loss and impairment of physiological integrity and
function with a subsequent increased risk of disease and
death [1,2]. The biologic mechanisms of aging are only
partly understood, but include genomic instability, telomere
attrition, cellular senescence, epigenetic alterations, loss of
protein homeostasis (proteostasis), dysregulated nutrient
sensing, mitochondrial dysfunction, altered intercellular* Correspondence: geneticmedicine@med.cornell.edu
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unless otherwise stated.communication and stem cell exhaustion [1,2]. Similar to
other organs, the lung demonstrates a progressive decrease
in lung function in healthy individuals [3,4]. Epidemio-
logical studies have demonstrated that smoking results in
accelerated lung function decline over time, suggesting
smoking accelerates aging of the lung [3,5]. In support of
this concept, telomere length analysis of blood leukocytes
has demonstrated that smoking is associated with short-
ened telomeres [6-18].
Based on the data indicating that smoking accelerates
the aging-related decline in lung function, and that
smokers have shorter telomere lengths in blood leuko-
cytes, we hypothesized that cigarette smoking accelerates
aging of the small airway epithelium, the cell population
directly exposed to the inhaled toxins from the cigarette
smoke, and one of the primary sites in the lung toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Demographics of the study population and
biologic samples for analysis of aging signature gene







Gender (M/F) 16/13 22/7
Age (yr) 38.0 ± 12.4 38.8 ± 10.1 >0.8
Race (B/W/O)2 10/8/11 13/8/8
Smoking history (pack-yr) 0 17.8 ± 8.4
Urine nicotine (ng/ml) negative 1657 ± 1527
Urine cotinine (ng/ml) negative 1929 ± 1060
Pulmonary function
parameters3
FVC 106.9 ± 12.1 111.1 ± 11.6 >0.17
FEV1 106.3 ± 12.2 109.4 ± 13.1 >0.35
FEV1/FVC 82.8 ± 4.9 81.0 ± 4.3 >0.13
TLC 99.7 ± 17.3 97.6 ± 14.1 >0.6
DLCO 90.4 ± 9.6 86.0 ± 5.4 <0.04
Body mass index (BMI) 26.4 ± 5.3 27.8 ± 4.8 >0.3
Epithelial cells4
% epithelial cells 98.9 ± 0.9 99.2 ± 0.8 >0.2
% inflammatory cells 1.0 ± 0.8 0.8 ± 0.8 >0.2
Differential cell count5
Ciliated (%) 71.3 ± 5.3 62.9 ± 6.9 <0.00001
Secretory (%) 10.0 ± 4.5 12.3 ± 6.4 >0.12
Basal (%) 9.5 ± 6.6 9.6 ± 6.6 >0.96
Undifferentiated
columnar (%)
8.2 ± 4.9 14.5 ± 8.2 <0.001
1Data is presented as mean ± standard deviation.
2B = Black, W =White, O = Other.
3Pulmonary function testing parameters are given as % predicted value with
the exception of FEV1/FVC, which is reported as % observed; FVC – forced vital
capacity, FEV1 – forced expiratory volume in 1 sec. FVC, FEV1 and FEV1/FVC are
post-bronchodilator values. TLC – total lung capacity, DLCO – diffusing capacity
of the lung for carbon monoxide.
4Small airway epithelium.
5As % of small airway epithelium recovered.
6Smoker vs Nonsmoker comparison by student’s t-test with p < 0.05 being
significant.
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smoking [19-25]. To assess the effect of cigarette smoking
on small airway epithelium aging, we compared age
matched healthy nonsmokers and healthy smokers with
no clinical manifestation of lung disease using the sensi-
tive biologic parameters of gene expression and telomere
length. Analysis of small airway epithelium gene ex-
pression levels demonstrated that smoking significantly
dysregulates expression of an aging gene signature [26].
Further, telomere length analysis in an independent cohort
of age matched male subjects revealed that smoking
significantly reduced telomere length in the small air-
way epithelium. Overall, these data provide biologic
evidence that before the manifestation of lung function
decline, smoking accelerates aging of the small airway
epithelium by dysregulation of age-related gene expres-
sion and enhanced telomere erosion.
Methods
Study population
Healthy nonsmokers and healthy smokers were recruited
from the general population in New York City. Individ-
uals were evaluated at the Weill Cornell and Rockefeller
University NIH Clinical and Translational Science Centers
and the Department of Genetic Medicine Clinical Re-
search Facility, using Institutional Review Board-approved
clinical protocols and signed informed consent prior to
any procedures. The criteria for “healthy” was based on
history, physical exam, complete blood count, coagulation
studies, liver function tests, urine studies, chest X-ray,
EKG and pulmonary function tests (for full inclusion/
exclusion criteria, see Additional file 1, Methods)
[25,27,28]. All subjects were negative for HIV1 and had
normal α1-antitrypsin levels. Smoking status was verified
by urine nicotine and cotinine levels. Nonsmokers were
defined as self-reported life-long nonsmokers, with non-
detectable urine nicotine (<2 ng/ml) and cotinine (<5 ng/ml);
and smokers were defined as self-reported current
smokers with urine nicotine ≥30 ng/ml and/or urine
cotinine ≥50 ng/ml. Two independent age matched co-
horts of nonsmokers and smokers were used in this study
to analyze the effects of smoking on small airway epithe-
lium age-related gene expression (Table 1) and telomere
length (Table 2).
Small airway epithelial sampling
Small airway epithelium (10th to 12th order) was collected
by fiberoptic bronchoscopy by brushing as previously de-
scribed [25,27,28]. Following withdrawal of the broncho-
scope, the cells were dislodged from the brush by flicking
the brush tip in 5 ml of ice-cold bronchial epithelium
basal medium (BEBM, Lonza, Basel, Switzerland). An ali-
quot of all airway epithelial samples was used to quantify
the total number of cells recovered, and to quantify thepercentage of epithelial and inflammatory cells and the
proportions of epithelial cell subtypes. Cells from a second
aliquot were pelleted for either RNA or DNA extraction
for subsequent transcriptome or telomere length analysis,
respectively.
RNA and microarray processing
Pelleted small airway epithelial cells obtained by bron-
choscopy were immediately processed for RNA extrac-
tion and microarray analysis as previously described
[25,27,28]. Total RNA was extracted from the small airway
epithelium of 29 nonsmokers and 29 smokers (Table 1)
using the TRIzol method (Invitrogen) with subsequent
Table 2 Demographics of the study population and









Gender All male All male
Age (yr) 39.0 ± 12.9 43.9 ± 7.6 >0.14
Race (B/W/O)2 8/6/7 14/3/5
Smoking history (pack-yr) 0 22.6 ± 9.0
Urine nicotine (ng/ml) negative 1424 ± 1432
Urine cotinine (ng/ml) negative 1359 ± 993
Pulmonary function
parameters3
FVC 103.1 ± 10.9 110.4 ± 8.5 <0.03
FEV1 105.4 ± 11.1 107.5 ± 8.2 >0.48
FEV1/FVC 83.9 ± 4.8 79.1 ± 3.7 <0.002
TLC 102.0 ± 14.6 96.2 ± 12.7 >0.17
DLCO 93.3 ± 11.8 87.2 ± 7.7 >0.05
Body mass index (BMI) 27.8 ± 4.5 26.0 ± 3.9 >0.16
Epithelial cells4
% epithelial cells 97.5 ± 1.4 99.1 ± 0.8 <0.0001
% inflammatory cells 2.5 ± 1.4 0.9 ± 0.8 <0.0001
Differential cell count5
Ciliated (%) 62.3 ± 5.8 57.9 ± 7.1 <0.03
Secretory (%) 11.0 ± 5.1 17.3 ± 6.0 <0.0006
Basal (%) 5.8 ± 4.2 5.6 ± 4.5 >0.97
Undifferentiated
columnar (%)
18.4 ± 5.8 18.3 ± 8.6 >0.90
1Data is presented as mean ± standard deviation.
2B = Black, W =White, O = Other.
3Pulmonary function testing parameters are given as % predicted value with
the exception of FEV1/FVC, which is reported as % observed; FVC – forced vital
capacity, FEV1 – forced expiratory volume in 1 sec. FVC, FEV1 and FEV1/FVC are
post-bronchodilator values. TLC – total lung capacity, DLCO – diffusing capacity
of the lung for carbon monoxide.
4Small airway epithelium.
5As % of small airway epithelium recovered.
6Smoker vs Nonsmoker comparison by student’s ttest with p < 0.05 being
significant.
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kit (Qiagen, Valencia, CA) and stored in RNAsecure
(Ambion, Austin, TX) at −80°C. RNA quality was assessed
using a Bioanalyzer (Agilent Technologies, Santa Clara,
CA) to determine RNA integrity (RIN value) with only
samples displaying a RIN >6 included in this study and
concentration quantified with a NanoDrop ND-1000 spec-
trophotometer (NanoDrop Technologies, Wilmington,
DE). One μg of total RNA was prepared for microarray
genome-wide transcriptome analysis using the 3’IVT Ex-
press Kit (Affymetrix, Santa Clara, CA) and samples were
submitted to the Genomics Resources Core Facility at
Weill Cornell Medical College for hybridization, washingand scanning of the Affymetrix HG U133 Plus 2.0 micro-
array GeneChips. All HG-U133 Plus 2.0 microarrays were
processed according to Affymetrix protocols, hardware
and software, including being processed by the Affymetrix
fluidics station 450 and hybridization oven 640 and
scanned with an Affymetrix Gene Array Scanner 3000 7G.
The captured image data from the HG-U133 Plus 2.0
arrays were processed using the MAS5 algorithm in
GeneSpring version 7.3 (Affymetrix Microarray Suite
Version 5) and normalized per chip to the median ex-
pression value of each sample to generate P calls for fil-
tering. Overall microarray quality was verified by the
criteria: (i) 3′/5’ ratio for GAPDH ≤3; and (ii) scaling
factor ≤10.0. CEL files were processed by Partek Genomics
Suite Software version 6.6 (Partek, Inc., St Louis, MO) for
quality control, identification of outliers and determination
of expression level for all probesets, using the Robust
Multi-chip Average (RMA) method with Partek default
parameters.
Microarray data analysis
Genes containing U133 2.0 microarray probesets and an
Affymetrix P call in ≥10% of samples were considered to
be expressed in the small airway epithelium. To confirm
the genome wide transcriptional changes in response to
smoking the phenotypes were evaluated in Partek for
sources of variation and an ANOVA was performed to as-
sess the effect of smoking on gene expression corrected
for all covariates, including age, gender, race and region
(small airway epithelium from distal right vs distal left
lower lobe of the lung). Smoking-dependent differences in
expression identified by Students t test and a p < 0.05
(using a Benjamini-Hochberg correction to limit the false
discovery rate) were considered to represent a significant
difference in expression between groups. Global patterns
of expression were examined using a euclidean dissimilar-
ity and average linkage hierarchical cluster analysis. To as-
sess the effect of smoking on aging of the small airway
epithelium, we compared healthy smoker vs healthy non-
smoker small airway epithelium expression of a 73 gene
aging signature identified by de Magalhaes et al. [26] by
meta-analysis of age-related gene expression profiles using
27 datasets from mice, rats and humans representing a
common signature of aging between different species and
tissues. Using criteria described above to define small air-
way epithelial expression resulted in removal of 6 genes
from the analysis with a final aging signature of 67 genes
(Additional file 1: Table S1). The phenotypes were evalu-
ated in Partek for sources of variation and an ANOVA
was performed to assess the effect of smoking on gene ex-
pression corrected for all covariates, including age, gender,
race and region (small airway epithelium from distal right
vs distal left lower lobe of the lung). Smoking-dependent
differences in expression identified by Students t test and
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the false discovery rate) were considered to represent a
significant difference in expression between groups. Glo-
bal patterns of expression of the 67 aging-related genes
were examined using principal component analysis (PCA).
The raw data and full dataset are publically available at
the Gene Expression Omnibus (GEO) site (http://www.
ncbi.nlm.nih.gov/geo/), accession number GSE52237.
Immunohistochemistry
To analyze expression of aging genes in the small airway
epithelium at the protein level immunohistochemistry
analysis was performed. Commercially available biopsy
sections of paraffin embedded normal human bronchus
tissue (Cat No: HuFPT111, US Biomax, Inc., Rockville,
MD) were purchased for 3 independent donors (Donor
1: 21 yr old female, Donor 2: 16 yr old female and Donor
3: 37 yr old male). The samples were first cleaned in xy-
lene and rehydrated with graded ethanol followed by
steaming the samples for 15 min in citrate buffer solu-
tion (Thermo Scientific), followed by cooling at 23°C for
20 min to recover antigens and enhance staining. En-
dogenous peroxidase activity was quenched using 0.3%
H2O2 for 30 min, followed by incubation for 20 min
with normal serum matched to the secondary antibody
to reduce background staining. Samples were incubated
overnight at 4°C with the following primary antibodies
all purchased from Abcam (Cambridge, MA) at specific
individual concentrations: rabbit polyclonal anti-C3 anti-
body (ab129945, 0.2 μg/ml), rabbit polyclonal anti-CX3CL1
antibody (ab85034, 0.2 μg/ml), rabbit monoclonal anti-CLU
antibody (ab92548, 0.2 μg/ml), rabbit polyclonal anti-
LAPTM5 antibody (ab108014, 0.2 μg/ml), rabbit monoclo-
nal anti-MGST1 antibody (ab131059, 1 μg/ml) and rabbit
monoclonal anti-SPP1 antibody (ab91655, 0.2 μg/ml).
Isotype-matched IgG (Jackson ImmunoResearch Labora-
tories Inc., West Grove, PA) was used as a negative control.
The Vectastain Elite ABC kit and AEC substrate kit (Dako
North America Inc., Carpinteria, CA) were used to visualize
antibody binding and slides were counterstained with
Mayer’s hematoxylin (Polysciences Inc., Warrington, PA)
and mounted using faramount mounting medium (Dako
North America Inc.). Images were acquired using a Nikon
Microphot microscope with a Plan 40 ×N.A. 0.70 objective
lens and an Olympus DP70 CCD camera.
Analysis of telomere length
Pelleted small airway epithelial cells obtained by bronchos-
copy or blood derived leukocytes were processed for DNA
extraction using the Qiagen Puregene kit (Germantown,
MD). DNA was extracted from the small airway epithelium
of 21 male nonsmokers and 22 male smokers and matched
blood derived leukocytes of a subset of 12 nonsmokers and
16 smokers (Table 2) and the telomere length for eachsample determined by Southern analysis using the Telo-
TAGGG telomere length assay kit (Roche Applied Science,
Indianapolis, IN). Briefly, 1 μg of purified DNA was
digested with the restriction enzymes HinfI plus RsaI (20 U
each) in a 20 μl reaction volume for 2 hr, 37°C. The reac-
tion was stopped by adding gel loading buffer. Digested
DNA was separated by electrophoresis on a 0.8% agarose
gel in Tris-acetate ethylenediaminetetraacetic acid (EDTA)
buffer at 5 V/cm for 4 h and transferred to a nylon mem-
brane by Southern analysis using 3 M NaCl plus 0.3 M so-
dium citrate buffer pH 7.0 for 16 hr. The transferred DNA
was fixed by UV-crosslinking (120 mJ) to the nylon mem-
brane. The terminal restriction fragments (TRFs) were hy-
bridized to a digoxigenin (DIG)-labeled probe specific for
telomeric repeats for 1 hr, 42°C, followed by incubation
with a DIG-specific antibody covalently coupled to alkaline
phosphatase for 30 min, 25°C. Finally, the immobilized telo-
mere probe on the membrane was detected by incubation
with CDP-Star, a chemiluminescent substrate, followed by
exposure to an X-ray film. The film was then scanned with
a densitometer and the mean TRF length was calculated
using Image quant TL software (GE Healthcare, Port
Washington, NY). Samples were analyzed in an un-blinded
fashion; however to minimize the effect of variability be-
tween experiments, equal numbers of nonsmoker and
smoker samples were run on each gel (see Additional file 1:
Figure S1 for representative gels).
Statistics
Comparison of demographic parameters among groups
was performed by 2-tailed Students t test. For the HG-
U133 Plus 2.0 gene expression data, an ANOVA was per-
formed to assess the effect of smoking significance on gene
expression corrected for all covariates, including age, gen-
der, ethnicity and region. Differences in expression were
evaluated by Students t test and a p < 0.05, using a
Benjamini-Hochberg correction to limit the false discovery
rate, was considered to represent a significant difference in
expression between groups. The difference in mean telo-
mere (TRF) length between phenotypes was calculated by
2-tailed Students t test and a p value <0.05 was considered
to represent a significant difference in length between
groups. Correlations between mean telomere length and
age as well as smoking history were done using both uni-
variate and multivariate linear regression and calculated
using commercial software (Stata 10.1, StataCorp, College
Station, TX). A p < 0.05 was considered to represent a sta-
tistically significant correlation.
Results
Effect of smoking on aging-related genes in the small
airway epithelium
To assess the effect of smoking on aging-related gene
expression in the small airway epithelium we used a
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healthy smokers (n = 29; Table 1). Cell differential ana-
lysis of the small airway epithelial brushes of non-
smokers and smokers demonstrated epithelial cells were
the major dominant cell population with a small amount
of inflammatory cells. However, no significant differences
(p > 0.2) in the total epithelial (nonsmokers, 98.9 ± 0.9%
and smokers, 99.2 ± 0.8%) and inflammatory (nonsmokers,
1.0 ± 0.8% and smokers, 0.8 ± 0.8%) cell populations be-
tween phenotypes was observed. To confirm the effect of
smoking at the mRNA level in our study cohort, we per-
formed genome wide transcriptional analysis to identify
the total number of smoking dysregulated transcripts in
the small airway epithelium. We hypothesized that small
changes in gene expression would indicate the early stages
of smoking dependent changes on accelerating aging of
the airway/lung. Therefore, we rationalized that a 20% dif-
ference in gene expression (i.e., 1.2-fold) would be an ac-
ceptable cutoff to robustly detect smoking dependent
changes and result in functional biological changes at the
protein level for each gene. A volcano plot demonstrated
there were 2488 differentially expressed probesets which
represent a total of 1737 unique genes (947 down-
regulated by smoking and 790 up-regulated by smoking)
using criteria of presence of U133 2.0 microarray pro-
besets and a P call criteria of ≥10% of samples, fold-
change ≥1.2 and adjusted p < 0.05 with false discovery
rate correction for multiple comparisons corrected for
all covariates, including age, gender, race and region
(distal right vs distal left lower lobe; Figure 1A). Un-
supervised hierarchical cluster analysis using the 2488
smoking-dysregulated probesets revealed complete sep-
aration of smoker and nonsmoker small airway epithelial
subjects (Figure 1B).
To assess the effect of smoking on aging-related gene
expression in the small airway epithelium, we analyzed
expression levels of a common 73 gene aging signature
identified from meta-analysis of age-related gene expres-
sion profiles using datasets from mice, rats and humans
[26]. Due to the multiple cell types used in the meta-
analysis, the aging signature is not specific for epithelial
or pulmonary cells per se, thus preventing the study of
small airway epithelial specific aging genes in response
to smoking. However, it likely represents ubiquitously
expressed genes that are involved in the natural aging
process of all cell types. Based on the presence of U133
2.0 microarray probesets and a P call criteria of ≥10% of
samples to be considered expressed, 67 genes of the
aging signature were expressed in the small airway epi-
thelium of healthy nonsmokers and smokers (Additional
file 1: Table S1). Principal component analysis, using the
67 genes as an input dataset, demonstrated clear separ-
ation of the samples by smoking phenotype when cor-
rected for all covariates, including age, gender, race andregion (distal right vs distal left lower lobe; Figure 2A).
A volcano plot identified 13 significantly up-regulated
genes and 5 significantly down-regulated genes using
criteria of fold-change ≥1.2 and adjusted p < 0.05 with
false discovery rate correction for multiple comparisons
(Figure 2B). Of the 13 genes significantly up-regulated
by smoking, 11 demonstrated the same direction of ex-
pression observed with aging (SPP1, LAPTM5, ANXA3,
MPEG1, MGST1, MSN, CLU, FCGR2B, GSTA1, LITAF,
and VAT1), whereas 2 demonstrated the opposite direc-
tion of expression observed with aging (COL3A1 and
GHITM; Table 3) [26]. Of the 5 genes significantly down-
regulated by smoking, 2 demonstrated the same direction
of expression observed with aging (C4A and CX3CL1),
whereas 3 demonstrated the opposite direction of expres-
sion observed with aging (MT1F, PCSK6 and C3) [26]. As
an alternative strategy we assessed expression of the 67
gene aging signature in the list of 1737 unique smoking
dysregulated genes identified in our cohort (Figure 1).
Using this approach 14/67 (ANXA3, C3, C4A, CLU,
CX3CL1, GHITM, GSTA1, LITAF, MGST1, MPEG1,
MSN, MT1F, PCSK6 and SPP1) aging signature genes
were present in the smoking dysregulated gene list. These
14 aging genes were all present in our original approach
which identified 18/67 aging genes to be dysregulated in
response smoking. These data demonstrate that independ-
ent of the analytic strategy the smoking dependent
changes in expression of the aging gene signature are con-
sistent. To validate these gene expression findings, correl-
ation analysis was carried out on the 18 aging genes
differentially expressed in the small airway epithelium by
comparing smoker vs nonsmoker fold-changes in the
U133 gene expression with U133 and RNA Seq gene ex-
pression data from two independent datasets of age-
matched samples [25,27]. The results demonstrate a high
degree of correlation in expression pattern of the 18
aging-related genes dysregulated by smoking with both
the U133 (r2 = 0.85) and RNAseq (r2 = 0.90) datasets
(Figure 2C-D). Due to the lack of availability of small
airway epithelial biopsies from nonsmokers and smokers,
we were unable to quantify and assess the smoking
dependent mRNA gene expression changes we observed
at the protein level. However, to demonstrate epithelial
expression of the aging related genes we performed im-
munohistochemistry staining analysis of commercially
available normal human bronchus sections from 3 inde-
pendent donors for 6 of the aging signature genes
whose expression are dysregulated by smoking: C3,
clusterin (CLU), CX3CL1, LAPTM5, MGST1 and
SPP1. The staining results clearly demonstrate that all 6
genes are epithelial expressed (Figure 3). Overall, these
data demonstrate that smoking results in significant ab-
normal expression of a number of aging-related genes
in the small airway epithelium.
Figure 1 Smoking dysregulated genes in the small airway epithelium. A. Volcano plot, smoker vs nonsmoker small airway epithelium (n = 29
nonsmokers and n = 29 smokers) using all expressed (P call ≥10) probesets as input dataset. Ordinate – p value; abscissa – fold-change (log2). Data
demonstrates 2488 smoking-dysregulated probesets [fold-change ≥1.2, p < 0.05 with false discovery rate (FDR) correction] representing a total of 1737
unique genes. B. Hierarchical cluster analysis of smoker vs nonsmoker small airway epithelium based on expression of 2488 smoking-dysregulated
probesets [fold-change ≥1.2, p < 0.05 with false discovery rate (FDR) correction]. Probesets expressed above the average are represented in red, below
average in blue and average in grey. The probesets are represented horizontally and individual samples vertically.
Walters et al. Respiratory Research 2014, 15:94 Page 6 of 13
http://respiratory-research.com/content/15/1/94Effect of smoking on telomere length in the small airway
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The effect of smoking on aging of the small airway epi-
thelium was assessed using telomere length analysis as
an alternative marker of aging in an independent cohort
of age-matched healthy nonsmokers and smokers
(Table 2). Because of the known differences in telomere
length between males and females [29] we restricted the
analysis to only males. Telomere length of DNA ex-
tracted from the small airway epithelium was assessed
by Southern analysis of HinfI and RsaI digested total
DNA and the mean terminal restriction fragment (TRF)
length calculated for each sample. In healthy non-
smokers (n = 21) the mean TRF length was 7.69 ± 1.41 kb
whereas in age-matched healthy smokers (n = 22), the
mean TRF length was 6.65 ± 1.16 kb, and significantly
shorter (p < 0.005; Figure 4A). As expected, in the healthynonsmokers, telomere length significantly decreased with
age (r2 = 0.20, p < 0.05; Figure 4B). In contrast, in healthy
smokers there was no significant decrease in telomere
length with age (r2 = 0.001, p > 0.8). Telomere length in
smokers was not dependent on smoking history, with no
correlation between telomere length and pack-yr (r2 = 0.014,
p > 0.6; Figure 4C). To assess the effect of race on smoking
dependent telomere shortening in the small airway epi-
thelium, we compared telomere length in the small air-
way epithelium of smokers vs nonsmokers subdivided
by racial categories (Black, White and Other). The re-
sults demonstrate that in each racial subgroup there is
a trend of shorter telomeres in smokers vs nonsmokers
(Black, 6.77 ± 0.92 kb vs 7.61 ± 1.28 kb; White, 5.88 ±
0.35 kb vs 7.57 ± 1.32 kb and Other, 6.77 ± 0.55 kb vs
7.86 ± 1.55 kb; Additional file 1: Figure S2). Due to the
small sample size for each subgroup statistical significance
Figure 2 Expression of an aging gene signature in small airway epithelium of age matched healthy smokers vs healthy nonsmokers.
A. Principal component analysis of gene expression of small airway epithelium of smokers (n = 29, orange circles) and nonsmokers (n = 29, green
circles) using the de Magalhaes et al. [26] 67 gene aging signature as an input dataset. Data is corrected for all covariates except smoking status.
B. Volcano plot, smoker vs nonsmoker small airway epithelium of the 67 aging gene signature. Ordinate – p value (log10); abscissa – fold-change
(log2). Red circles represent genes significantly differentially expressed in smoker vs nonsmoker small airway epithelium (≥1.2 fold-change up- or
down-regulated; p < 0.05 using a Benjamini-Hochberg correction of false discovery rate). C. Correlation analysis of the 18 aging genes differentially
expressed in the small airway epithelium of healthy smokers vs healthy nonsmokers, comparing smoker vs nonsmoker fold-changes in U133 gene
expression with U133 gene expression from an independent dataset (n = 12 nonsmokers and n = 10 smokers, GSE4498) [25]. D. Correlation analysis of
the 18 aging genes differentially expressed in the small airway epithelium of healthy smokers vs healthy nonsmokers, comparing smoker vs nonsmoker
fold-changes in U133 gene expression with RNA Seq gene expression from an independent dataset (n = 5 nonsmokers and n = 6 smokers) [27].
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White smokers vs nonsmokers (p < 0.03), however due to
consistency of the smoking dependent effects on telomere
length between racial subgroups the data suggests that
race plays no significant role in smoking dependent telo-
mere shortening of the small airway epithelium.
Previous studies have shown that telomere length is
shorter in peripheral blood leukocytes of smokers com-
pared to nonsmokers [6-18]. Cell differential analysis of
the small airway epithelial brushes of nonsmokers and
smokers demonstrated epithelial cells were the dominant
cell population with a small amount of inflammatory
cells. However, there was a significantly lower level of in-
flammatory cells in the brushings of smokers compared
to nonsmokers (0.9% vs 2.5%, p < 0.0001; Table 2)suggesting the reduced telomere length we observe in
the small epithelium of smokers does not result from
the presence of inflammatory cells and are specific for
the epithelial cell populations. In support of this, we
measured the telomere length in the peripheral blood
leukocytes of a subset of age matched nonsmokers (n =
12/21) and smokers (n = 16/22) (40.8 ± 9.7 yrs non-
smokers and 46 ± 6.4 yrs smokers, p > 0.12). The results
demonstrated no significant differences (p > 0.1) in the
telomere length of peripheral blood leukocytes in
smokers vs nonsmokers (7.04 ± 0.71 kb vs 7.42 ± 0.54 kb;
Additional file 1: Figure S3). However, in the same sam-
ples we still observe a significant decrease (p < 0.002) in
the telomere length of the small airway epithelium in
smokers vs nonsmokers (6.49 ± 0.74 kb vs 7.95 ±




Gene symbol Gene title Fold-change2 p value3 Direction of expression
with aging4
Up-regulated SPP1 Secreted phosphoprotein 1 13.48 3.1x10−5 Over
LAPTM5 Lysosomal protein transmembrane 5 1.75 3.8x10−2 Over
ANXA3 Annexin A3 1.72 2.2x10−3 Over




MSN Moesin 1.39 2.6x10−2 Over
CLU Clusterin 1.38 3.6x10−3 Over
COL3A1 Collagen, type III, alpha 1 1.34 4.3x10−2 Under
FCGR2B Fc fragment of IgG, low








GHITM Growth hormone inducible
transmembrane protein
1.25 3.1x10−5 Under
VAT1 Vesicle amine transport protein
1 homolog (T. californica)
1.22 4.3x10−3 Over




C4A Complement component 4A −2.45 3.2x10−4 Under
CX3CL1 Chemokine (C-X3-C motif) ligand 1 −2.50 3.0x10−6 Under
C3 Complement component 3 −2.73 2.1x10−3 Over
1List of aging genes based on de Magalhaes et al. [26]; listed are the genes with significantly different expression in the small airway epithelium of healthy
smokers vs healthy nonsmokers; for the data for all of the de Magalhaes et al. “aging genes”, see Additional file 1: Table S1.
2Fold-change - mean in healthy smokers/mean in healthy nonsmokers.
3False discovery rate, p < 0.05, Partek Benjamini-Hochberg correction.
4Direction of expression observed with aging, see de Magalhaes et al. [26].
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mere length observed in the small epithelium of smokers
is specific for the epithelial cell populations. Overall,
these data suggest that smoking prematurely ages the
small airway epithelium with smokers displaying on
average telomere lengths ~14% shorter than chrono-
logically age-matched healthy nonsmokers.Discussion
During the natural aging process of healthy individuals,
the lung undergoes a progressive decrease in lung func-
tion [3,4]. Studies have demonstrated that cigarette
smoking accelerates the rate of lung function decline,
suggesting that smoking results in premature aging of
the lung [3,5]. The small airway epithelium consists of 4
major cell types that line the airway lumen ≥6th genera-
tions and take the initial brunt of inhaled toxins from
the cigarette smoke [20,21,24]. The earliest abnormalitiesand pathology linked to smoking and development of
COPD manifest in the small airway epithelium [19,22,23],
and biologic changes in the small airway epithelium in re-
sponse to cigarette smoking can be observed long before
the presence of pathology [25,27,30]. The focus of this
study was to determine if cigarette smoking results in ac-
celerated aging of the small airway epithelium at the mo-
lecular level before physical manifestation of lung disease
or lung function decline. To address this question we used
the sensitive molecular parameters of aging-related gene
expression and telomere length to compare the aging
process of the small airway epithelium in age matched
healthy nonsmokers and healthy smokers. The data dem-
onstrate that smoking significantly dysregulates expression
of an aging gene signature in the small airway epithelium,
with ~26% of the aging genes (18/67) up or down-
regulated greater than 1.2-fold in response to smoking.
Over 72% (13/18) of the 18 smoking dysregulated genes
demonstrate the same direction of expression observed
Figure 3 Immunohistochemical staining analysis of smoking
dysregulated aging genes in the small airway epithelium.
Normal nonsmoker human bronchus sections from 3 independent
donors were analyzed for expression of C3, clusterin (CLU), CX3CL1,
LAPTM5, MGST1 and SPP1 using gene specific antibodies. Isotype
specific antibody was used as negative control. Scale bar 20 μm.
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process in the small airway epithelium. In support of
this concept, telomere length analysis in the small air-
way epithelial cells of an independent cohort of age
matched male subjects revealed smoking status had a
significant impact on telomere length, with smokersFigure 4 Telomere length in the small airway epithelium of nonsmok
of male healthy nonsmokers (n = 21) and male healthy smokers (n = 22) an
Southern analysis. A. Data shown is represented as the average ± standard
between phenotypes was calculated by 2-tailed Students t test. B. Correlat
Southern analysis and correlated with the age of each individual subject. C
using linear regression. Black circles represent healthy nonsmokers and gre
with smoking history (pack-yr). Telomere length from healthy smokers was
history for each individual subject. Correlations between mean telomere ledisplaying on average a ~14% decrease in telomere
length compared to nonsmokers. One of the limitations
of this study is the presence of multiple cell types and
epithelial subsets in the brushings obtained during
bronchoscopy which makes it difficult to determine the
individual cell type responsible for the accelerated aging
in response to smoking. However, the epithelial brushes
we analyze are processed immediately upon collection
thus reducing any potential artifacts from downstream
processing and thus represent a true reflection of the
in vivo environment. In addition, the differences in
number of epithelial cell subsets (ciliated, secretory,
basal and undifferentiated columnar) between non-
smokers and smokers may allow inference towards the
cell populations responsible for the smoking dependent
changes we observe at the gene expression level and in
telomere length and suggest that specific cell popula-
tions are more susceptible to the aging effects of
cigarette smoke. Currently the biological consequences
of smoking-dependent changes in age related gene ex-
pression and telomere shortening in the small airway
epithelium on lung function decline and/or clinical disease
in smokers are unknown. In addition, it is currently un-
known if the effects of aging gene dysregulation and telo-
mere shortening are mutually exclusive with each
contributing independently to development of specific
lung disease (e.g. COPD vs lung cancer) or both processes
are biologically connected and contribute equally to devel-
opment of disease. Future studies dissecting the biological
consequences of each molecular phenomenon will help
clarify their role in development of specific lung diseases.
However, based on the known function of the aging signa-
ture genes and telomeres we can postulate potential con-
sequences of these changes.ers and smokers. DNA was isolated from the small airway epithelium
d telomere length [terminal restriction fragment (TRF)] quantified by
deviation of the TRF length (kb). The difference in mean TRF length
ion of telomere length with age. Telomere length was quantified by
orrelations between mean telomere length and age were performed
y circles represent healthy smokers. C. Correlation of telomere length
quantified by Southern analysis and correlated with the smoking
ngth and smoking history were performed using linear regression.
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in the small airway epithelium
Characterization of the biological processes associated
with the original 73 gene aging signature identified by de
Magalhaes et al. [26] highlighted enrichment for genes
involved in multiple cellular processes, including im-
mune response, inflammation, mitochondrial function,
metabolism, lysosomes, collagen, apoptosis, cell cycle
and markers of cellular senescence. Pathway analysis of
the 18 smoking dysregulated genes failed to identify en-
richment of a single biological process. However, based
on the known biological functions of a subset of these
genes, we can hypothesize how they may play a role in
regulating the response of the small airway epithelium to
cigarette smoke exposure and their potential contribu-
tion to the development of long-term pathological
changes associated with smoking.
Based on the hypothesis that age-related gene expres-
sion changes may have a protective role in mediating the
harmful effects of cellular dysfunction over-time, smoking-
induced expression of these genes may serve a similar role.
For instance, increased expression of the anti-oxidant genes
MGST1 and GSTA1 in smokers most likely protects
against elevated levels of harmful oxidants [31-33]. In
addition, elevated expression of the protein chaperone clus-
terin (CLU) may curtail the effects of protein mis-folding
and aggregation in response to cigarette smoke [34,35].
Alternatively, dysregulated expression of some genes
may play a key role in driving the pathological changes
associated with cigarette smoking. SPP1, the most highly
induced smoking-responsive aging gene, encodes osteo-
pontin, a secreted cytokine-like molecule that mediates
immune function and extracellular matrix (ECM) remod-
eling [36]. A recent study demonstrated that cigarette
smoke-dependent up-regulation of SPP1 expression medi-
ates induction of emphysema in an experimental mouse
model [37]. In addition, asbestos exposure in a murine
lung fibrosis model results in up-regulation of SPP1 in
bronchiolar epithelial cells [38]. Microarray analysis com-
paring lungs of wild-type and SPP1 knockout mice ex-
posed to asbestos showed that SPP1 modulated
expression of a number of genes involved in cell signal-
ing, immune system/defense, cell cycle regulation and
ECM remodeling [38]. Therefore, elevated expression
of SPP1 in the small airway epithelium of smokers may
have significant long term pathological consequences
and may play a key role in the process of airway remod-
eling characterized in smoking-induced respiratory dis-
ease such as COPD.
While a majority of the smoking dysregulated aging
genes (13/18) displayed the same direction of smoking-
induced expression as that observed with aging, the
remaining 5 genes (COL3A1, GHITM, MT1F, PCSK6 and
C3) demonstrated the opposite direction of expressionobserved with aging. At present, the long-term biological
consequence of these alternate expression patterns is un-
known. However, studies for COL3A1, which encodes for
collagen 3A1, have shown that expression of this gene is
positively regulated by SPP1 in a murine model of
asbestos-induced lung fibrosis and that over-expression of
the gene is linked to fibrosis and tissue remodeling [38].
Therefore, while COL3A1 expression generally decreases
with aging over time to possibly reduce age-related tissue
remodeling, smoking-induced expression may contribute
significantly to the increased incidence of airway remodel-
ing in individuals with smoking-induced respiratory
disease such as COPD [19,22,23,39,40]. Similarly to
COL3A1, the putative tumor suppressor gene MT1F may
contribute to smoking-induced pathological changes.
MT1F expression is typically down-regulated in a majority
of human colon tumor tissues and its enforced expression
can result in increased apoptosis and inhibition of cell mi-
gration, invasion and in vivo tumorigenicity [41]. There-
fore, the general increase in expression of MT1F during
aging may function as a protective mechanism to prevent
development of cancer, whereas smoking-dependent
down-regulation in the small airway epithelium may con-
tribute to the increased risk of developing lung cancer in
smokers [42]. However, additional in vitro studies need to
be performed to demonstrate a role of MT1F in develop-
ment of lung cancer in addition to following subjects over
time to confirm the correlation between MT1F expression
and development of lung cancer and/or COPD.
Consequence of telomere length changes in the small
airway epithelium
Based on the hypothesis that COPD is a disease of accel-
erated aging [43-46], a number of different studies have
analyzed the effect of smoking and COPD status on telo-
mere length in blood leukocytes [6-18]. While some
have demonstrated that smokers (independent of COPD
status) have shorter blood leukocyte telomeres compared
to nonsmokers [6,7,10-13], others have shown that
COPD status, but not smoking is associated with short-
ened telomeres [15-18]. Recent findings from a large
study group of 46,396 individuals from the Danish gen-
eral population demonstrate that blood leukocyte short
telomere length is associated with decreased lung func-
tion and increased risk of COPD [8]. Furthermore, a
meta-analysis of blood leukocyte telomere length and
COPD from nine independent European studies demon-
strated shorter telomere length in COPD subjects com-
pared with healthy controls [14]. Our study is the first to
look at the effect of smoking on telomere length in the
small airway epithelium and demonstrates that smoking
accelerates telomere shortening in this cell population
critical to lung function prior to the development of
lung disease and lung function decline. In addition, our
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kocytes in a subset of the nonsmokers and smokers in
our study suggest the small airway epithelium is more
sensitive to the telomere shortening effects of cigarette
smoke exposure than peripheral blood leukocytes. In
contrast to studies of blood leukocyte telomere length,
we observed no negative correlation of telomere length
with pack-yr. In our analysis we did not correct for con-
founders such as age and obesity as no significant differ-
ences are observed in these parameters between our
nonsmoker and smoker groups. The presence of add-
itional confounders may explain the lack of negative as-
sociation of telomere length with pack-yr; alternatively it
may result from the narrow range of pack-yr of our sub-
jects which may prevent identification of an association.
In addition, from a biological perspective a small amount
of cigarette smoke exposure may result in significant ef-
fects on telomere length, therefore, masking any effect be-
tween individuals with medium to high pack-yr. The long
term biological consequences of smoking-dependent telo-
mere shortening in the small airway epithelium are un-
known, however based on the function of telomeres, one
may postulate a number of possible outcomes.
Telomeres are specialized regions at the ends of linear
chromosomes comprised of TTAGGG repeats that play
a key role in maintaining chromosome stability and are
linked to aging [47]. In germ cells, telomeres are main-
tained by the enzyme complex telomerase; however, lack
of expression of telomerase in somatic tissues results in
decreased telomere length following each round of cell
division [47]. Once telomere length shortens to a specific
point, a DNA damage response is elicited that is largely
p53-dependent, resulting in reduced replication potential
of the cell and activation of senescence with subsequent
removal of the cells by apoptosis [48-51]. The numbers
of senescent cells are known to increase in tissues during
the natural aging process either due to an increase in
their generation or decrease in their removal [2]. In con-
trast to normal cells, senescent cells are known to adopt
an altered phenotype highlighted by loss of proliferative
activity, persistence of active metabolism, altered secre-
tome (enriched in pro-inflammatory cytokines and
matrix metalloproteinases) and resistance to apoptosis
which can lead to loss of tissue homeostasis [49,51,52].
Therefore, smoking-dependent accelerated telomere
shortening may increase the rate at which cells of the
small airway epithelium reach cell senescence. In sup-
port of this concept, in vivo studies have shown that alveo-
lar epithelial cells from COPD smokers have increased
numbers of senescent cells relative to healthy controls
[53,54]. Furthermore, during normal aging increased ex-
pression of the smoking-induced aging gene CLU is used
as a marker for cell senescence [55]. Therefore, our gene
expression data supports the hypothesis that telomereshortening may increase the rate of senescence in the
small airway epithelium. In addition, studies of lung endo-
thelial cells from COPD smokers demonstrated they
reached senescence earlier during in vitro culture relative
to nonsmokers and in doing so, adopted an abnormal
secretory phenotype with secretion of a diverse array of
cytokines known to play a role in inflammation and airway
remodeling [56]. Senescent cells within the small airway
may adopt a similar function and secrete mediators that
further drive smoking-induced pathology and airway
remodeling.
An alternative consequence of shorter telomere length
in the small airway epithelium maybe a decline in resi-
dent stem/progenitor cell function similar to what is ob-
served in other aging tissues [2,47]. Basal cells are the
stem/progenitor population of cells in the small airways
that differentiate into the other specialized epithelial cell
types of the airway during normal epithelial turnover
and repair [57-59]. In vitro studies have demonstrated
that continuous culture of these cells to a senescent
state results in diminished differentiation capacity
[60,61]. Therefore, reduced telomere length in the airway
basal cells of smokers may result in impaired differenti-
ation capacity leading to disordered cell differentiation
and airway epithelial remodeling [58]. In support of this,
the first manifestation of smoking-induced pathology
in vivo of the small airway epithelium is basal cell hyper-
plasia which is characterized by increased proliferation
and expansion of the basal cell population [19]. How-
ever, at present we have no evidence suggesting telomere
length in the basal cell population is reduced in response
to cigarette smoke exposure. Future studies identifying
the exact cell populations of the small airway epithelium
that are more sensitive to smoking-dependent telomere
shortening will help further our understanding of the
biological consequences of this phenomenon.
To date, the evidence clearly shows that short telo-
mere length is associated with incidence of specific lung
diseases; however, it is unknown whether telomere
shortening itself drives the pathological processes in the
lung or whether this phenomenon itself is a bystander
and just a consequence of other processes at work. A re-
cent study using telomerase null mice with short telo-
meres demonstrated that short telomeres alone was not
sufficient to induce spontaneous lung disease; however,
when mice with short telomeres were experimentally ex-
posed to cigarette smoke, they had a lower threshold to
develop emphysema [62]. These findings suggest that
multiple factors contribute to the development of
cigarette smoke-induced airway disease and that telo-
mere length, at least in part, plays a partial active role in
“sensitizing” the cells to further damage and destruction.
Therefore, similar mechanisms may be conserved in
humans, and individuals with short telomeres may be of
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COPD.
Conclusion
In summary, these data provide evidence that smoking
accelerates aging of the small airway epithelium at the
molecular level. Future studies analyzing the function of
smoking-induced aging-related genes and telomeres in
small airway epithelium biology may help identify new
therapeutic targets to treat smoking-induced lung
disease.
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